Contact
Please use this form to send email to PR contact of this press release:
PhotoPharmics Expands Enrollment Beyond 300 in Groundbreaking Trial to Show Improvement Beyond Current Therapies
TO:
Spokesperson
PhotoPharmics
+1 801-361-6600